https://www.fondazionecharta.org/pubblicazione/ 2025-11-04T00:02:41+00:00 https://www.fondazionecharta.org/en/pubblicazione/ 2025-11-04T00:02:41+00:00 https://www.fondazionecharta.org/pubblicazione/the-value-based-healthcare-approach-to-haemophilia-development-of-outcome-measures-for-the-evaluation-of-care-of-people-with-haemophilia/ 2025-11-03T23:56:00+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_pubblicazioni_haemophilia.jpg https://www.fondazionecharta.org/en/pubblicazione/the-value-based-healthcare-approach-to-haemophilia-development-of-outcome-measures-for-the-evaluation-of-care-of-people-with-haemophilia/ 2025-11-03T23:56:28+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_pubblicazioni_haemophilia.jpg https://www.fondazionecharta.org/pubblicazione/treatment-patterns-in-essential-tremor-real-world-evidence-from-a-united-kingdom-and-france-primary-care-database/ 2025-11-03T23:57:21+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_pubblicazioni_europeam_journal_neurology.jpg https://www.fondazionecharta.org/en/pubblicazione/treatment-patterns-in-essential-tremor-real-world-evidence-from-a-united-kingdom-and-france-primary-care-database/ 2025-11-03T23:58:00+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_pubblicazioni_europeam_journal_neurology.jpg https://www.fondazionecharta.org/pubblicazione/a-cost-consequence-analysis-of-adding-pertuzumab-to-the-neoadjuvant-combination-therapy-in-her2-positive-high-risk-early-breast-cancer-in-italy/ 2025-11-03T23:58:37+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_pubblicazioni_the_breast.jpg https://www.fondazionecharta.org/en/pubblicazione/a-cost-consequence-analysis-of-adding-pertuzumab-to-the-neoadjuvant-combination-therapy-in-her2-positive-high-risk-early-breast-cancer-in-italy/ 2025-11-03T23:58:55+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_pubblicazioni_the_breast.jpg https://www.fondazionecharta.org/pubblicazione/anti-inhibitor-coagulant-complex-prophylaxis-in-hemophilia-with-inhibitors/ 2025-11-03T23:59:54+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_new_england_journal_medicine.jpg https://www.fondazionecharta.org/en/pubblicazione/anti-inhibitor-coagulant-complex-prophylaxis-in-hemophilia-with-inhibitors/ 2025-11-04T00:00:20+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_new_england_journal_medicine.jpg https://www.fondazionecharta.org/pubblicazione/safety-and-effectiveness-of-oral-rivaroxaban-versus-standard-anticoagulation-for-the-treatment-of-symptomatic-deep-vein-thrombosis-xalia-an-international-prospective-non-interventional-study/ 2025-11-04T00:01:01+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_lancet_haematology.jpg https://www.fondazionecharta.org/en/pubblicazione/safety-and-effectiveness-of-oral-rivaroxaban-versus-standard-anticoagulation-for-the-treatment-of-symptomatic-deep-vein-thrombosis-xalia-an-international-prospective-non-interventional-study/ 2025-11-04T00:01:23+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_lancet_haematology.jpg https://www.fondazionecharta.org/pubblicazione/healthcare-resource-utilization-in-patients-with-newly-diagnosed-atrial-fibrillation-a-global-analysis-from-the-garfield-af-registry/ 2025-11-04T00:01:53+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_pubblicazioni_healtcare.jpg https://www.fondazionecharta.org/en/pubblicazione/healthcare-resource-utilization-in-patients-with-newly-diagnosed-atrial-fibrillation-a-global-analysis-from-the-garfield-af-registry/ 2025-11-04T00:02:41+00:00 http://www.fondazionecharta.org/wp-content/uploads/2025/09/charta_pubblicazioni_healtcare.jpg